Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years

This press release from the U.S. Food and Drug Administration details the updated emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine.

View Resource This link goes to an outside website which could be a PDF or other non-webpage item.

Details

The below links are specific for NPHIC resources

Topics: COVID-19

Types: Media Campaign-PSAs

Sources: FDA

Back To Top
Search